Hedgehog signalling pathway inhibitors as cancer suppressing agents
- 11 December 2013
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 5 (2) , 117-133
Abstract
The Hedgehog (Hh) signalling pathway plays a pivotal role in the spatial and temporal regulation of cell proliferation and differentiation. By controlling the correct maturation of developing tissues and ensuring attainment of the correct size, position and the presence of fully functioning cellular structures, the Hh plays a pivotal role in development. Conversely aberrant Hh signalling is involved in Gorlin syndrome, basal cell carcinoma (the most common cancer in the world), and more than one third of all human medulloblastoma cases. In all of these cases, it is believed that deregulated Hh signalling leads to increased cell proliferation and tumour formation. Inhibition of the Hedgehog signalling pathway, is a recently validated anti-cancer drug target, with vismodegib (Erivedge™), approved by the U.S. Food and Drug Administration for the treatment of adult basal cell carcinoma. In this perspective we outline the current state of Hh pathway inhibitors with a particular focus on potential limitations of upstream Hh pathway inhibition in relation to resistance mutations and crosstalk pathways. Together, these limitations indicate that inhibition of downstream components, specifically the Gli family of transcription factors, may represent a next generation approach to suppress tumours associated with aberrant Hh pathway signalling.Keywords
This publication has 133 references indexed in Scilit:
- Crosstalk between TGF‐β and hedgehog signaling in cancerFEBS Letters, 2012
- Amide conjugates of ketoprofen and indole as inhibitors of Gli1-mediated transcription in the Hedgehog pathwayBioorganic & Medicinal Chemistry, 2010
- NANOG regulates glioma stem cells and is essential in vivo acting in a cross‐functional network with GLI1 and p53The EMBO Journal, 2010
- Hedgehog controls neural stem cells through p53‐independent regulation of NanogThe EMBO Journal, 2010
- Human colon cancer epithelial cells harbour active HEDGEHOG‐GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansionEMBO Molecular Medicine, 2009
- Structure−Activity Relationships and Cancer-Cell Selective Toxicity of Novel Inhibitors of Glioma-Associated Oncogene Homologue 1 (Gli1) Mediated TranscriptionJournal of Medicinal Chemistry, 2009
- Hedgehog-Gli Signaling Pathway Inhibitors as Anticancer AgentsJournal of Medicinal Chemistry, 2009
- A GLI1‐p53 inhibitory loop controls neural stem cell and tumour cell numbersThe EMBO Journal, 2009
- PATCHED-ONE or SMOOTHENED Gene Mutations Are Infrequent in ChondrosarcomaClinical Orthopaedics and Related Research, 2008
- Mutations affecting segment number and polarity in DrosophilaNature, 1980